|
Market Closed -
Nasdaq
02:30:00 20/11/2024 am IST
|
5-day change | 1st Jan Change | ||
| 4.840 USD | +3.20% |
|
-.--% | - |
| 21/24/21 | Exscientia plc(NasdaqGS:EXAI) dropped from S&P Global BMI Index | CI |
| 20/24/20 | Recursion Pharmaceuticals, Exscientia Complete Business Combination | MT |
| Market Cap | 50Cr 67Cr 58Cr 55Cr 93Cr 6.4TCr 94Cr 655.37Cr 252.81Cr 3.24TCr 250.54Cr 245.19Cr 10TCr | P/E 2022 |
-4.55x | P/E 2023 | -4.28x |
|---|---|---|---|---|---|
| Enterprise Value | 16Cr 21Cr 18Cr 17Cr 29Cr 1.99TCr 29Cr 204.16Cr 79Cr 1.01TCr 78Cr 76Cr 3.24TCr | EV / Sales 2022 |
1.9x | EV / Sales 2023 | 14.2x |
| Free-Float |
36.87% | Yield 2022 * |
-
| Yield 2023 | - |
| 1 day | +3.20% |
| 3 years | 3.8 |  | 7.91 |
| 5 years | 3.8 | | 30.38 |
| 10 years | 3.8 | | 30.38 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Tech/Sci/R&D Officer | 61 | 06/06/2024 | |
| Chief Tech/Sci/R&D Officer | - | 01/05/2022 | |
John Overington
CTO | Chief Tech/Sci/R&D Officer | - | 01/05/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Mario Polywka
BRD | Director/Board Member | 63 | 28/09/2017 |
Robert Ghenchev
BRD | Director/Board Member | 43 | 01/05/2020 |
Elizabeth Crain
CHM | Chairman | 61 | 12/02/2024 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +3.20% | -.--% | -.--% | -5.84% | 63Cr | |
| +1.23% | +1.30% | -0.69% | +9.57% | 4.59TCr | |
| +0.23% | +4.85% | +44.23% | +27.27% | 4.42TCr | |
| +0.52% | -5.17% | +340.58% | +520.09% | 4.2TCr | |
| +1.55% | +0.70% | +8.03% | +76.45% | 3.96TCr | |
| +1.75% | -1.53% | +12.22% | +41.11% | 3.11TCr | |
| -0.20% | +4.93% | +25.35% | +119.72% | 1.72TCr | |
| -3.49% | -8.35% | - | - | 1.63TCr | |
| +2.92% | +8.37% | +22.73% | +38.87% | 1.5TCr | |
| -2.45% | +6.38% | -1.99% | -35.16% | 1.34TCr | |
| Average | +0.53% | +1.38% | +50.05% | +88.01% | 2.65TCr | |
| Weighted average by Cap. | +0.59% | +0.68% | +70.97% | +120.29% |
| 2022 | 2023 | |
|---|---|---|
| Net sales | 2.72Cr 3.64Cr 3.17Cr 3Cr 5.09Cr 348.79Cr 5.11Cr 36Cr 14Cr 176.37Cr 14Cr 13Cr 567.14Cr | 2.01Cr 2.68Cr 2.34Cr 2.21Cr 3.75Cr 257.26Cr 3.77Cr 26Cr 10Cr 130.09Cr 10Cr 9.85Cr 418.31Cr |
| Net income | -12Cr -16Cr -14Cr -13Cr -22Cr -1.52TCr -22Cr -155.67Cr -60Cr -769.21Cr -60Cr -58Cr -2.47TCr | -15Cr -19Cr -17Cr -16Cr -27Cr -1.87TCr -27Cr -191.38Cr -74Cr -945.65Cr -73Cr -72Cr -3.04TCr |
| Net Debt | -49Cr -66Cr -57Cr -54Cr -92Cr -6.3TCr -92Cr -644.98Cr -248.8Cr -3.19TCr -246.57Cr -241.3Cr -10TCr | -34Cr -46Cr -40Cr -38Cr -64Cr -4.41TCr -65Cr -451.2Cr -174.05Cr -2.23TCr -172.49Cr -168.81Cr -7.17TCr |
Employees
483
- Stock Market
- Stocks
- EXAI Stock
Select your edition
All financial news and data tailored to specific country editions
